new_0222_0440|HOWL|Short Name|0|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return
new_0222_0440|HOWL|Long Name|1|1|Werewolf Therapeutics Inc Total Current Assets (Quarterly) (USD)|Werewolf Therapeutics Inc Cash and Short Term Investments (Quarterly) (USD)|Werewolf Therapeutics Inc Inventories (Quarterly) (USD)|Werewolf Therapeutics Inc Net PP&E (Quarterly) (USD)|Werewolf Therapeutics Inc Goodwill and Intangibles (Quarterly) (USD)|Werewolf Therapeutics Inc Total Liabilities (Quarterly) (USD)|Werewolf Therapeutics Inc Total Current Liabilities (Quarterly) (USD)|Werewolf Therapeutics Inc Total Long Term Liabilities (Quarterly) (USD)|Werewolf Therapeutics Inc Total Deposits (Quarterly) (USD)|Werewolf Therapeutics Inc Book Value (Quarterly) (USD)|Werewolf Therapeutics Inc Retained Earnings (Quarterly) (USD)|Werewolf Therapeutics Inc Treasury Stock (Quarterly) (USD)|Werewolf Therapeutics Inc EV to Revenues|Werewolf Therapeutics Inc EV to Earnings|Werewolf Therapeutics Inc EV to Free Cash Flow|Werewolf Therapeutics Inc EV to Assets (Quarterly)|Werewolf Therapeutics Inc PS Ratio|Werewolf Therapeutics Inc PE Ratio|Werewolf Therapeutics Inc Price to Book Value|Werewolf Therapeutics Inc PEG Ratio|Werewolf Therapeutics Inc Debt to Equity Ratio|Werewolf Therapeutics Inc Dividend Yield|Werewolf Therapeutics Inc Shareholder Yield (TTM)|Werewolf Therapeutics Inc Percent of Shares Outstanding Short|Werewolf Therapeutics Inc Total Receivables (Quarterly) (USD)|Werewolf Therapeutics Inc Total Payables (Quarterly) (USD)|Werewolf Therapeutics Inc Total Capital Stock (Quarterly) (USD)|Werewolf Therapeutics Inc Return on Invested Capital|Werewolf Therapeutics Inc Quality Ratio Score|Werewolf Therapeutics Inc Momentum Score|Werewolf Therapeutics Inc Beta (1Y)|Werewolf Therapeutics Inc Sustainable Growth Rate (TTM)|Werewolf Therapeutics Inc Institutional Investor Ownership Percentage|Werewolf Therapeutics Inc Average Diluted Shares Outstanding (Quarterly)|Werewolf Therapeutics Inc Total Employees (Annual)|Werewolf Therapeutics Inc EPS Diluted (Quarterly) (USD)|Werewolf Therapeutics Inc Shares Outstanding|Werewolf Therapeutics Inc Repurchase of Capital Stock (Quarterly) (USD)|Werewolf Therapeutics Inc Ordinary Shares Number (Quarterly)|Werewolf Therapeutics Inc Payout Ratio|Werewolf Therapeutics Inc Quick Ratio (Quarterly)|Werewolf Therapeutics Inc Normalized Diluted EPS (Quarterly) (USD)|Werewolf Therapeutics Inc Stock Buybacks (Quarterly) (USD)|Werewolf Therapeutics Inc Effective Tax Rate (TTM)|Werewolf Therapeutics Inc Return on Equity|Werewolf Therapeutics Inc Net Income (TTM) (USD)|Werewolf Therapeutics Inc Revenue (TTM) (USD)|Werewolf Therapeutics Inc Dividend Per Share (Quarterly) (USD)|Werewolf Therapeutics Inc Revenue (Quarterly) (USD)|Werewolf Therapeutics Inc Gross Profit (Quarterly) (USD)|Werewolf Therapeutics Inc SG&A Expense (Quarterly) (USD)|Werewolf Therapeutics Inc Pre-Tax Income (Quarterly) (USD)|Werewolf Therapeutics Inc Net Income (Quarterly) (USD)|Werewolf Therapeutics Inc Net Interest Income (Quarterly) (USD)|Werewolf Therapeutics Inc Price (USD)|Werewolf Therapeutics Inc Total Return Price (USD)|Werewolf Therapeutics Inc Enterprise Value (USD)|Werewolf Therapeutics Inc 30-Day Average Daily Volume|Werewolf Therapeutics Inc 1 Year Price Returns (Daily)
new_0222_0440|HOWL|Unit|2|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric
new_0222_0440|HOWL||4|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|quarterly
new_0222_0440|HOWL||5|5|91|91|0|91|0|91|91|91|0|91|91|0|0|0|1.44334975369|0|0|0|1.43827160494|0|0|1.44334975369|0|15.3333333333|0|91|91|0|0|0|0|0|31|91.3333333333|91.5|91.3333333333|27.5714285714|0|91|0|0|91.3333333333|91.4|0|0|91|0|0|0|0|91.3333333333|91.3333333333|91.3333333333|91.3333333333|1.44117647059|1.44117647059|1.44334975369|1.44252873563|0
new_0222_0440|HOWL||6|6|3|3|0|3|0|3|3|3|0|3|3|0|0|0|203|0|0|0|162|0|0|203|0|18|0|3|3|0|0|0|0|0|1|6|2|6|7|0|3|0|0|6|5|0|0|3|0|0|0|0|6|6|6|6|204|204|203|174|0
new_0222_0440|HOWL||7|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily
new_0222_0440|HOWL|202003|202003|202003||||||||||||||||||||||||||||||||||8.9707||-0.4266||||||-0.4266|||||||||1.131|-3.827|-3.827|0.067|||||
new_0222_0440|HOWL|202006|202006|202006||||||||||||||||||||||||||||||||||8.9707||0.2481||||||0.2516|0||||||||1.285|2.257|2.257|0.024|||||
new_0222_0440|HOWL|202009|202009|202009||||||||||||||||||||||||||||||||||8.9707||-0.6764||||||-0.6764|0||||||||1.241|-6.068|-6.068|-0.015|||||
new_0222_0440|HOWL|202012|202012|202012|92.914|92.57||3.122||148.261|5.284|142.977||-51.863|-51.865|||||||||||||||1.021|0.002|||||||8.9707||-0.8217|||27.568|||-0.8251|0|||-15.04|||||2.106|-7.402|-7.402|0.028|||||
new_0222_0440|HOWL|202103|202103|202103|84.865|84.602||2.999||243.19|5.409|237.781||-153.754|-153.756|||||||||||||||1.8|0.002|||||||26.2894|28|-3.8971|||27.568|||-0.2828||||-18.648|||||2.635|-7.435|-7.435|0.033|||||
new_0222_0440|HOWL|202104|202103|202103|||||||||||||||-15.8228|||||||0||0|||||||||0.1133||||27.5394||||||||||||||||||16.1|16.1|358.7823||
new_0222_0440|HOWL|202105|202103|202103|||||||||||||||-14.3411|||||||0||3.0579|||||||||31.0979||||27.5394||||||||||||||||||14.88|14.88|325.1843||
new_0222_0440|HOWL|202106|202106|202106|186.359|183.233||2.824||8.862|7.37|1.492||181.556|-221.268||||-10.2938||||2.6481|||0||4.1938||3.193|0.002|||||||17.75|31|-3.82|27.568||27.568|||-3.82|-111.6|||-31.826|||||3.691|-10.921|-10.921|0.051|17.44|17.44|297.5529|162547.3333|
new_0222_0440|HOWL|202107|202106|202106|||||||||||||||-10.2747||||2.6451|||0||2.4572|||||||||||||||||||||||||||||||17.42|17.42|297.0016|118087.6|
new_0222_0440|HOWL|202108|202106|202106|||||||||||||||-10.637||||2.7028|||0||2.3629|||||||||||||27.5677||||||||||||||||||17.8|17.8|307.4721|28404.3|
new_0222_0440|HOWL|202109|202109|202109|174.404|170.438||2.752||9.072|7.775|1.297||169.303|-235.026||||-8.1389||||2.7588|||0||2.4367||1.457|0.002|||||||27.188|36|-0.51|27.219||27.219|||-0.51|0|||-39.516|||||4.008|-13.758|-13.758|0.037|17.16|17.16|296.64|15146.8|
new_0222_0440|HOWL|202110|202109|202109|||||||||||||||-7.0262||||2.5193|||0||2.4984|||||||||||||||||||||||||||||||15.67|15.67|256.0837|15897.5|
new_0222_0440|HOWL|202111|202109|202109|||||||||||||||-6.2883||||2.3604|||0||2.3636|||||||||||||27.5795||||||||||||||||||14.49|14.49|229.189|47210.4333|
new_0222_0440|HOWL|202112|202112|202112|||||||||||||||-4.336||||1.9401|||0||2.8344|||||||||||||||||||||||||||||||11.91|11.91|158.0338|188805.9|
new_0222_0440|HOWL|202201|202112|202112|||||||||||||||-2.2172||||1.484|||0||1.0304|||||||||||||||||||||||||||||||9.11|9.11|80.8112|154889.9667|
new_0222_0440|HOWL|202202|202112|202112|||||||||||||||-0.4844||||1.124|||0|||||||||||||||||||||||||||||||||6.9|6.9|17.6542|66257.9333|